Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,535 JPY | -5.89% | -5.42% | -6.66% |
May. 09 | Sankyo Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2025 | CI |
Apr. 29 | AstraZeneca makes progress with Truqap and Enhertu cancer treatments | AN |
Business Summary
Number of employees: 864
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pachinko Machine-related
77.9
%
| 71,860 | 84.7 % | 122,576 | 77.9 % | +70.58% |
Pachislot Machine Related
14.3
%
| 8,891 | 10.5 % | 22,551 | 14.3 % | +153.64% |
Supply Equipment Related
7.6
%
| 3,895 | 4.6 % | 11,993 | 7.6 % | +207.91% |
Others
0.1
%
| 210 | 0.2 % | 175 | 0.1 % | -16.67% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 84,857 | 100.0 % | 157,296 | 100.0 % | +85.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Akihiko Ishihara
CEO | Chief Executive Officer | 61 | 86-03-31 |
Chairman | 71 | 77-03-31 | |
Sou Busujima
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Administrative Officer | - | - | |
Ichiro Tomiyama
COO | Chief Operating Officer | 66 | 86-10-31 |
Yoko Oshima
IRC | Investor Relations Contact | - | - |
Katsumasa Takai
PRN | Corporate Officer/Principal | - | - |
Toshio Ogura
PRN | Corporate Officer/Principal | - | - |
Yuji Togo
SAM | Sales & Marketing | - | - |
Takashi Fukuda
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 77-03-31 | |
Akihiko Ishihara
CEO | Chief Executive Officer | 61 | 86-03-31 |
Ichiro Tomiyama
COO | Chief Operating Officer | 66 | 86-10-31 |
Taro Kitani
BRD | Director/Board Member | 48 | 15-05-31 |
Director/Board Member | 69 | 18-06-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 260,000,000 | 145,874,115 ( 56.11 %) | 40,651,855 ( 15.64 %) | 56.11 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
SANKYO CO., LTD. 15.64% | 40,651,855 | 15.64% | 449,642,851 $ |
1,401,000 | 9.56% | 24,808,754 $ | |
533,400 | 0.07% | 11,658,710 $ | |
200,000 | 0.70% | 8,431,068 $ | |
377,400 | 1.66% | 8,116,798 $ | |
RESONA HOLDINGS, INC. 0.03% | 666,750 | 0.03% | 4,186,543 $ |
DAIKOKU DENKI CO., LTD. 0.13% | 19,100 | 0.13% | 482,722 $ |
Company contact information
Sankyo Co., Ltd.
3-29-14 Shibuya Shibuya-Ku
150-8327, Tokyo
+81 3 5778 7777
http://www.sankyo-fever.co.jpSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.66% | 2.3B | |
+4.50% | 662M | |
-30.79% | 656M | |
+24.70% | 351M | |
+34.52% | 447M | |
-3.43% | 304M | |
-27.86% | 214M | |
+6.33% | 168M | |
-2.37% | 77.86M | |
-28.80% | 63.24M |
- Stock Market
- Equities
- 6417 Stock
- Company Sankyo Co., Ltd.